Assenagon Asset Management S.A. Has $1.18 Million Holdings in ORTHOFIX MEDICAL INC. (NASDAQ:OFIX)

Assenagon Asset Management S.A. increased its holdings in shares of ORTHOFIX MEDICAL INC. (NASDAQ:OFIX - Free Report) by 421.1% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 72,226 shares of the medical device company's stock after buying an additional 58,366 shares during the quarter. Assenagon Asset Management S.A. owned 0.19% of ORTHOFIX MEDICAL worth $1,178,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of OFIX. Rhumbline Advisers lifted its position in shares of ORTHOFIX MEDICAL by 1.2% during the 4th quarter. Rhumbline Advisers now owns 54,989 shares of the medical device company's stock worth $960,000 after buying an additional 661 shares during the last quarter. Versor Investments LP bought a new position in ORTHOFIX MEDICAL in the fourth quarter valued at about $499,000. Charles Schwab Investment Management Inc. raised its position in ORTHOFIX MEDICAL by 4.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 339,531 shares of the medical device company's stock valued at $5,928,000 after purchasing an additional 14,724 shares during the last quarter. Victory Capital Management Inc. raised its position in ORTHOFIX MEDICAL by 2.9% in the fourth quarter. Victory Capital Management Inc. now owns 66,675 shares of the medical device company's stock valued at $1,164,000 after purchasing an additional 1,868 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in ORTHOFIX MEDICAL in the fourth quarter valued at about $1,003,000. 89.76% of the stock is currently owned by institutional investors.

Insider Transactions at ORTHOFIX MEDICAL

In related news, CEO Massimo Calafiore acquired 10,000 shares of the stock in a transaction dated Friday, May 9th. The stock was bought at an average cost of $12.54 per share, for a total transaction of $125,400.00. Following the completion of the transaction, the chief executive officer now directly owns 234,603 shares of the company's stock, valued at $2,941,921.62. The trade was a 4.45% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jorge Andres Cedron sold 3,816 shares of the firm's stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $13.31, for a total value of $50,790.96. Following the sale, the insider now directly owns 42,500 shares of the company's stock, valued at $565,675. This represents a 8.24% decrease in their position. The disclosure for this sale can be found here. Insiders purchased 112,250 shares of company stock worth $1,380,970 over the last ninety days. 1.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. Canaccord Genuity Group reiterated a "buy" rating and issued a $24.00 target price on shares of ORTHOFIX MEDICAL in a research report on Wednesday, February 26th. Wall Street Zen upgraded ORTHOFIX MEDICAL from a "sell" rating to a "hold" rating in a research report on Saturday, June 14th. Roth Mkm reiterated a "buy" rating and issued a $22.00 target price on shares of ORTHOFIX MEDICAL in a research report on Wednesday, February 26th. Finally, JMP Securities reiterated a "market perform" rating on shares of ORTHOFIX MEDICAL in a research report on Friday, June 6th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, ORTHOFIX MEDICAL currently has an average rating of "Moderate Buy" and a consensus target price of $23.33.

ORTHOFIX MEDICAL Trading Down 0.1%

Shares of OFIX traded down $0.01 during mid-day trading on Friday, reaching $10.34. 814,462 shares of the company were exchanged, compared to its average volume of 281,301. ORTHOFIX MEDICAL INC. has a 52 week low of $10.25 and a 52 week high of $20.73. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.50 and a current ratio of 2.71. The stock has a market capitalization of $405.12 million, a PE ratio of -2.80 and a beta of 0.80. The business has a 50 day simple moving average of $12.08 and a two-hundred day simple moving average of $15.48.

ORTHOFIX MEDICAL Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.